X0202 4/A 2004-12-07 2004-12-08 0000707388 DIGIRAD CORP DRAD 0001238948 WOLLAEGER TIMOTHY J C/O KINGSBURY ASSOCIATES, L.P. 4401 EASTGATE MALL SAN DIEGO, CA 92121 1 0 0 0 Common Stock 2004-12-07 5 G 0 685 D 0 D Common Stock 2004-12-07 5 G 0 685 A 685 I By Kingsbury Associates, L.P. Common Stock 497885 I By Kingsbury Capital Partners, L.P. II Common Stock 306436 I By Kingsbury Capital Partners, L.P. III Common Stock 339766 I By Kingsbury Capital Partners, L.P., IV Common Stock 104428 I By Sanderling V Biomedical, L.P. Common Stock 42250 I By Sanderling V Limited Partnership Common Stock 426330 I By Sanderling Venture Partners V, L.P. Common Stock 37594 I By Sanderling V Beteiligungs GmbH & Co. KG Common Stock 68912 D Includes 685 shares received by reporting person in a distribution from Sanderling V Ventures Management and gifted by the reporting person to Kingsbury Associates, L.P. In prior reports, the reporting person reported beneficial ownership of 6,167 shares held by Sanderling V Ventures Management. Not applicable. The reporting person is the general partner of Kingsbury Associates, L.P., which is a general partner of each of Kingsbury Capital Partners, L.P. II, Kingsbury Capital Partners, L.P. III and Kingsbury Capital Partners, L.P., IV. The reporting person disclaims beneficial ownership of the shares held by Kingsbury Capital Partners, L.P. II, Kingsbury Capital Partners, L.P. III and Kingsbury Capital Partners, L.P., IV., except to the extent of his pecuniary interests in the named fund. As general partner, the reporting person has voting and investment power with respect to the shares held by Kingsbury Capital Partners, L.P. II, Kingsbury Capital Partners, L.P. III and Kingsbury Capital Partners, L.P., IV. The reporting person is the managing director of Middleton, McNeil & Mills Associates V, LLC, the general partner of Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG. The reporting person disclaims beneficial ownership of the shares held by Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG, except to the extent of his pecuniary interests in the named fund. The reporting person shares voting and investment power with respect to the shares held by Sanderling Venture Partners V, L.P., Sanderling V Biomedical, L.P., Sanderling V Limited Partnership and Sanderling V Beteiligungs GmbH & Co. KG with the other managing directors of Middleton, McNeil & Mills Associates V, LLC. Includes 67,332 shares received as a liquidating distribution from Kingsbury Capital Partners, L.P. In prior reports, the reporting person reported beneficial ownership of 505,807 shares held by Kingsbury Capital Partners, L.P. Timothy J. Wollaeger 2005-02-09